REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 159 filers reported holding REATA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,421,000 | +101.0% | 51,721 | +31.9% | 0.01% | +66.7% |
| Q4 2018 | $2,200,000 | -63.7% | 39,215 | -47.1% | 0.00% | -25.0% |
| Q3 2018 | $6,062,000 | +537.4% | 74,152 | +172.6% | 0.00% | +300.0% |
| Q2 2018 | $951,000 | +122.7% | 27,197 | +30.5% | 0.00% | 0.0% |
| Q1 2018 | $427,000 | -27.1% | 20,841 | +0.7% | 0.00% | 0.0% |
| Q4 2017 | $586,000 | +10.2% | 20,687 | +20.8% | 0.00% | 0.0% |
| Q3 2017 | $532,000 | +9.2% | 17,119 | +11.1% | 0.00% | 0.0% |
| Q2 2017 | $487,000 | +112.7% | 15,407 | +52.3% | 0.00% | – |
| Q1 2017 | $229,000 | +3.6% | 10,116 | 0.0% | 0.00% | – |
| Q4 2016 | $221,000 | -6.4% | 10,116 | +12.8% | 0.00% | – |
| Q3 2016 | $236,000 | +33.3% | 8,968 | 0.0% | 0.00% | – |
| Q2 2016 | $177,000 | – | 8,968 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |